MagnetOs Granules (PLF Study)
Instrumented Posterolateral Spinal Fusion
Level I ClinicalCompleted
Key Facts
Indication
Instrumented Posterolateral Spinal Fusion
Phase
Level I Clinical
Status
Completed
Company
About Kuros Biosciences
Kuros Biosciences is a commercial-stage orthobiologics company with a mission to deliver innovative biologic technologies for safer, faster, and more predictable bone healing. The company has achieved a global commercial footprint in over 20 markets and is building a robust Level I clinical evidence package through its Project Fusion research program. Its strategy centers on leveraging its proprietary NeedleGrip™ surface technology to address the significant clinical and economic burden of bone non-unions, aiming to become a leader in the $5B+ bone graft substitute market.
View full company profile